Innovative Digital Health Amiko's Respiro platform leverages connected inhalers combined with AI and data analytics, presenting opportunities to partner with pharmaceutical companies looking to enhance respiratory treatment adherence and digital solutions.

Strategic Partnerships With recent collaboration with Sanner Group to integrate sensor technology into pharmaceutical devices, there is potential to offer tailored sensor solutions and device integrations to medical device manufacturers and drug developers.

Expanding Market Presence Amiko competes with industry players like Propeller Health in the US and operates in a sizeable revenue bracket, indicating significant market traction and customer demand for advanced respiratory care solutions.

Robust Tech Stack Utilizing powerful tools such as MySQL, Shopify, and Mailchimp, Amiko maintains a scalable and customer-focused digital platform, opening opportunities for supporting or enhancing their online engagement, data management, and patient outreach strategies.

Growing Healthcare Focus With nearly 200 employees and substantial revenue, Amiko's focus on digital medicine and adherence solutions positions it as a promising partner for companies seeking innovative healthcare technology and digital health innovations.